J&J vaccine pause may be short, but deep concerns about staff hesitancy mounting
Two days after federal officials pressed pause on Johnson & Johnson’s COVID-19 vaccine, health and public policy leaders predicted it will return to use — but not without causing ongoing concern among key long-term care stakeholders.
